This article needs additional citations for verification. (February 2020) |
Clinical data | |
---|---|
Trade names | Propavan, others |
Other names | Propionylpromethazine; CB-1678; Wy-1359; NSC-169450 |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Routes of administration | Oral, IM, IV |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | Oral: 33%[2] |
Protein binding | 81%[3] |
Elimination half-life | 9 hours[2] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.006.043 |
Chemical and physical data | |
Formula | C20H24N2OS |
Molar mass | 340.49 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Propiomazine, sold under the brand name Propavan among others, is an antihistamine which is used to treat insomnia and to produce sedation and relieve anxiety before or during surgery or other procedures and in combination with analgesics as well as during labor.[4][additional citation(s) needed] Propiomazine is a phenothiazine,[4] but is not used therapeutically as a neuroleptic because it does not block dopamine receptors well.[citation needed]